Key Takeaways

A common heart attack drug doesn’t help many patients, clinical trial results show

People whose hearts escaped damage from a heart attack don’t benefit from beta-blockers

The drugs might harm the heart health of some women who’ve survived a heart attack

WEDNESDAY, Sept. 3, 2025 (HealthDay News) — A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found.

Beta-blockers do not appear to reduce the risk of death, a second heart attack or heart failure in people’s whose hearts weren’t damaged by the life-threatening event, results reveal.

The findings are expected to overturn treatment standards that have been in place for 40 years, researchers said.

“Currently, more than 80% of patients with uncomplicated myocardia

See Full Page